RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug duo tested to shield kidneys after cancer removal
Disease control TerminatedThis study tested whether two existing drugs, finerenone and empagliflozin, could help slow the decline of kidney function in patients at high risk after surgery to remove a kidney for cancer. Researchers compared patients taking one drug, both drugs, or no drug for one year to s…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Drug duo tested to shrink tumors before kidney cancer surgery
Disease control TerminatedThis study tested whether giving two drugs—an immunotherapy (toripalimab) and a targeted therapy (lenvatinib)—before and sometimes after kidney removal surgery could help shrink tumors and improve outcomes for people with kidney cancer. It aimed to see how much the treatment redu…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC